Riskpilot← Back to searchSign inGet full accessKynoRehab Esbjerg ApS
APSActiveCVR 37422347Smedevej 2Other personal service activities n.e.c. · NACE 9699Est. 20161 employees
Revenue 2025
DKK 132K
-436% vs 2024
EBITDA margin
5.9%
+120% vs 2024
Equity ratio
6.4%
Financial strength
Net profit 2025
DKK 5K
+117% vs 2024
| Revenue | DKK 132K | -436% |
| EBITDA | DKK 8K | +120% |
| Net profit | DKK 5K | +117% |
| Total assets | DKK 165K | +98% |
| Equity | DKK 10K | +96% |
| Employees | 1 | — |
Legal name
KynoRehab Esbjerg ApS
CVR number
37422347
Legal form
Anpartsselskab
NACE code
9699 · Other personal service activities n.e.c.
Founded
4. februar 2016
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Company purpose
Selskabets formål er at udøve virksomhed indenfor osteopati og massage til hunde samt handel med hundeartikler og anden virksomhed i forbindelse hermed efter direktionens skøn.
Address
Smedevej 2
Phone
+4524904189
Email
jkm3005@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -0 | -1 | -2 | -39 | 132 |
| Staff expenses | -0 | -0 | -0 | -0 | -124 |
| EBITDA | -0 | -1 | -2 | -39 | 8 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -0 | -1 | -2 | -39 | 8 |
| Net financials | -0 | -0 | -0 | -0 | -0 |
| Profit before tax | -0 | -1 | -2 | -39 | 8 |
| Tax | -0 | -0 | -0 | -9 | 3 |
| Net profit | -0 | -1 | -2 | -31 | 5 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 40 | 40 | 59 | 83 | 165 |
| Equity | 39 | 38 | 36 | 5 | 10 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 | 3 | 23 | 78 | 154 |
| Total debt | 1 | 3 | 23 | 78 | 154 |
EBITDA margin
5.9%
This company
15.8%
Market median
-63% vs market
20212025
Equity ratio
6.4%
This company
38.2%
Market median
-83% vs market
20212025
Return on equity
49.0%
This company
18.4%
Market median
+166% vs market
20212025
Net profit margin
3.9%
This company
8.1%
Market median
-52% vs market
20212025
Asset turnover
0.80×
This company
1.12×
Market median
-29% vs market
20212025
Debt / equity
14.74×
This company
0.62×
Market median
-2277% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
CK Management | Management | 2016 – 2017 |
NR Chief Executive Officer | Chief Executive Officer | 2017 – 2024 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2026 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KynoRehab Esbjerg ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Charlotte Kaasgaard Madsen | Management | 0 companies |
| Nikki René Madsen | Chief Executive Officer | 0 companies |